Key facts
- It has raised $230K.
- Notable investors include University of Toronto, University of Toronto Entrepreneurship, Innovation Factory (Hamilton), Communitech, BioTalent Canada — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Maman Biomedical
- ·The full record, as it builds
Funding rounds
No funding rounds for Maman Biomedical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Maman Biomedical
Developer of a microneedle drug-delivery platform designed to make hormone and fertility therapies safer and less invasive. The company offers a dissolving microneedle patch for hormone delivery, a device to replace daily injections, and a wearable biosensor with a mobile app to monitor hormone levels non-invasively through the skin, enabling patients undergoing hormone or fertility treatments to reduce pain, anxiety, and treatment burden.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2024
- Employees
- 6
- Website
- mamanbiomedical.ca/
- Ownership
- Privately Held (backing)
Maman Biomedical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Maman Biomedical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Maman Biomedical in its N-PORT filings yet. We sweep new filings monthly.